University of South Florida (USF) Health in Tampa, Fla., has enhanced their use of the Digisonics Cardiovascular Information System to include vascular reporting for improved workflow automation and efficiency.

Health and wellness screenings are more than just nice events for the community – they can save lives. A Mentor, Ohio, man learned this first-hand while attending Family Health and Safety Day at University Hospitals Concord Health Center in Painesville, Ohio.

Royal Philips introduced two new balloons to its Stellarex 0.035-inch low-dose drug-coated balloon (DCB) portfolio. The new 200mm and 150mm Stellarex 0.035-inch low-dose DCBs have received approval from the U.S. Food and Drug Administration (FDA) for the treatment of de novo and restenotic lesions in native superficial femoral or popliteal arteries, both arteries in the upper leg. The new balloons broaden physicians’ treatment options for peripheral artery disease (PAD) patients with a high risk of restenosis. The 200mm and 150mm Stellarex 0.035-inch low-dose DCBs are now available in the U.S. and will be rolled out to other markets in due course.

October 15, 2019 — Kardium Inc. announced that the Globe mapping and ablation system has successfully demonstrated ...

Medtronic plc announced the start of a worldwide pivotal study evaluating its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system to treat dangerously fast heart rhythms. The EV ICD system is designed to deliver lifesaving defibrillation and pacing therapy via a device the same size as traditional, transvenous ICDs, but with a lead (thin wire) placed outside the heart and veins.

October 10, 2019 — An independent analysis of Lutonix 035 drug-coated balloon (DCB) patient-level data showed no ...